AnnRheumDis1998;57:637–640637
Annals of the Rheumatic Diseases
Leader
Intra-articularhyaluronantreatmentforosteoarthritis
In1934MeyerandPalmerisolatedapolysaccharidefrombovinevitreoushumourandnamedithyaluronicacid.1ThenamederivesfromtheGreekword“hyalos”(thatis,glasslike).In1986Balazsetal2proposedthenamehyaluronanasanalternativetohyaluronicacid.“Hy-aluronicacid”,“sodiumhyaluronate”,and“HA”aretermsusedintheliteratureandfrequentlyinterchangeablywith“hyaluronan”,butthelatterhasbecomethepreferredname.
Inosteoarthritis(OA)thesynovial uid(SF)ismoreabundantandlessviscous,3theconcentrationofhyaluro-nanisdecreasedasisitschainlengthandthereforemolecularweight.4ThesechangesseverelydecreasethephysiologicalandprotectivefunctionsoftheSF5;shockabsorption,traumaticenergydissipationandstorage,lubricationandprotectivecoatingofthearticularcartilagesurfaceandoftheinnerliningofthesynovialmembrane,aswellascontrolofthe“traYc”betweenthesynovialvesselsandcartilagebyanexclusioneVectonmigratingcellsandlargemolecules.
Theconceptofviscosupplementation, rstproposedbyBalazs,6isbasedonthehypothesisthatintra-articularinjectionofhyaluronanintoOAjointscouldrestoretherheologicalpropertiesoftheSF,promotetheendogenoussynthesisofahighermolecularweightandpossiblymorefunctionalhyaluronan,therebyimprovingmobility,articu-larfunction,anddecreasingpain.Thismechanismissug-gestedbythe ndingofhyaluronanwithamolecularweightlargerthanthatoftheinjectedsolutionandwithintherangeofnormalSFhyaluronaninhumans7andanimals.8
Hyaluronanusedformedicaluseshastobeextractedfromumbilicalcord,roostercomborbacterialculturesthenpuri edandseparatedfromanypyrogenic,in amma-tory,immunogenicorchemotacticfractions.The rsttherapeuticinjectionsofhyaluronaninanimaljointswereperformedontrackhorsesfortraumaticarthritis,thetreatmentprovedeVectiveandsincethenhasbeenwidelyusedinveterinarymedicine.9
Preliminaryhumanclinicalstudieswereperformedintheearlyseventiesusingthenon-in ammatoryfractionofhyaluronan(NIF-NaHA).Healon(molecularweightabout2×106Da)becamethetradenameofthe rstNIF-NaHAproducedbyBiotricsInc(Arlington,MAUSA).ThistradenameforNIF-HAisnowusedbyPhar-maciaUpjohninophthalmicviscosurgery.Synvisc(Hyalangel uid20,(molecularweightabout7×106Da)Bioma-trix,NewJersey,USA)availableinCanadaandSwedenandrecentlylaunchedintheUK.Orthovisc(AnikaThera-peutics,USA)ismarketedinCanada,theNetherlands,andTurkey.Hyalgan(molecularweightabout5×105Da)Fida,Italy)hasbeenlaunchedinCanada,southeaseAsia,Italy,France,Germany,andsomeSouthAmericancountriesandisabouttobelaunchedintheUK.Artz(molecularweightabout7×105Da)SeikagakuKogyo,Japan)hasbeenlaunchedinJapanandSweden.Anumberofotherproductshavebeenorareunderdevelopmentforophthalmological,veterinary,andmusculoskeletalindica-tions.
OtherthantheobviouseVectsofintra-articularhyaluro-nanbysupplementationofthelubricatingpropertiesoftheSF,evidenceforothereVectsprimarilycomesfromanimalstudies.InvitrostudieshaveindicatedthathyaluronanhasawiderangeofeVectsonbothchondrocytesandsynovio-cytesandonthein ammatorycellsthatinvadethesynovialcavityduringosteoarthritis(OA).Invivostudiesinanimalmodelsandpreliminarystudiesinhumanshaveindicatedthathyaluronanmayprotectcartilagestructure,exertaneVectonthein ammatoryprocess,andreducepainbyactingdirectlyoncellreceptors.10Ithasbeenreportedthathyaluronanmaypreservechondrocytevitalityandcartilagestructure,11andreducesynovialcellproliferation,1213reducebradykinininducedpainwithhighmolecularweighthyaluronanandkaolinandcarrageenaninducedarthritis.14Itisspeculatedthathyaluronanmaybindin ammatorymediatorsandfreeradicals,removingthemfromthejointspacevialymphaticstherebyreducingcarti-lagedamage.15Figure1showssomeofthefunctionsofhyaluronan.
The rsttherapeuticstudiesinhumansofhyaluronaninkneeOAwerereportedbyRydellandBalazs16andPeyronandBalazs6andseveralyearslaterbyWeissetal.17Sincethenstudieshaveattemptedtodeterminenotonlyifintra-articularhyaluronaninOAisatherapeuticallyusefultech-niquebutalsooptimaltreatmentregimens—thatis,frequencyandnumberofinjections9andalsoifthemolecularweightoftheinjectedhyaluronanisanimportantdeterminantastoitseVectiveness.StudiesusingthehighermolecularweightpreparationshaveshownthemtobemoreeVectivewithagreaterdurationofaction.1718
Manycellscarryreceptorsforhyaluronanandthismol-eculemayeVectcell-cell,cell-matrix,andcell-receptor-ligandinteractions.16Forexample,interferencewiththe
George E. Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 1998;57:637-40. Oral Delivery of Hyaluronic Acid Absorbs Effectively in ...
George E. Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 1998;57:637-40. Oral Delivery of Hyaluronic Acid Absorbs Effectively in ...
Efficacy of intra-articular hyaluronan( Synvisc ) for the treatment of osteoarthritis affecting the first metatarsophalangeal joint of the foot ( hallux ...
Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action[J]. Arthritis Res Ther, 2003, 5(2):54...
Ostenil? hyaluronan injection is a new treatment for the symptoms of osteo...Viscosupplementation therapy with intra-articular hyaluronic acid – fact or ...
the basic physiology and treatment of osteoporosisOSTEOARTHRITIS risk factors: ...VI. Intra-articular corticosteroid and Hyaluronan 1) provides symptom relief,...
Moreland LW: Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003, 5...
Intra-articular corticosteroid treatment in osteoarthritis Curr Opin Orthop 2000,11:66-70. 关节腔内注射 ? 治疗对象:有关节滑膜炎及积液的患者,可用 消炎镇痛...
non pharmacological treatment for knee osteoarthritis_基础医学_医药卫生_专业...the progressive and frequently disabling destruction of articular cartilage (1)...
After Streptomyces hyaluronidase treatment, the ...Balazs, Effect of intra-articular injection of ...hyaluronan (hyaluronic acid) on anterior cruciate ...
热门文档